[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Epidermolysis Bullosa - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Epidermolysis Bullosa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Epidermolysis Bullosa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 154 pages

Hepatitis A - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Hepatitis A (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 33 pages

Narcolepsy - Pipeline Review, H1 2020

US$ 2,000.00

... . The Narcolepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 86 pages

Acne Vulgaris - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Acne Vulgaris (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 224 pages

Allergic Rhinitis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 164 pages

Angina (Angina Pectoris) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Angina (Angina Pectoris) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Angina (Angina Pectoris) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 78 pages

Atherosclerosis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Atherosclerosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Atherosclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 245 pages

Bone Metastasis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Bone Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bone Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 127 pages

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H1 2020

US$ 2,000.00

... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 276 pages

Endometriosis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 148 pages

Essential Thrombocythemia - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Essential Thrombocythemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Essential Thrombocythemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 115 pages

Fallopian Tube Cancer - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Fallopian Tube Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Fallopian Tube Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 1496 pages

Head And Neck Cancer - Pipeline Review, H1 2020

US$ 2,500.00

... . The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development ...

April 2020 2943 pages

Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Idiopathic Pulmonary Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 503 pages

Kidney Fibrosis - Pipeline Review, H1 2020

US$ 2,000.00

... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Kidney Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 174 pages

Measles - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Measles (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Measles and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 43 pages

Osteoarthritis Pain - Pipeline Review, H1 2020

US$ 2,000.00

... pipeline guide Osteoarthritis Pain - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Osteoarthritis Pain (Central Nervous System), complete with analysis by stage of development ...

April 2020 245 pages

Osteoporosis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 353 pages

Parkinson's Disease - Pipeline Review, H1 2020

US$ 2,500.00

... . The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 1201 pages

Peanut Allergy - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Peanut Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Peanut Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 158 pages

Peripheral Arterial Disease (PAD)/Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2020

US$ 2,000.00

... Arterial Disease (PAD) Peripheral Vascular Disease (PVD) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Peripheral Arterial Disease (PAD)/Peripheral Vascular Disease (PVD) and features dormant and discontinued projects. The guide covers therapeutics under ...

April 2020 232 pages

Premature Ejaculation - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 41 pages

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2020

US$ 2,000.00

... (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...

April 2020 278 pages

Rotavirus Infections - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Rotavirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rotavirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 55 pages

Stroke - Pipeline Review, H1 2020

US$ 2,500.00

... releases. The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 716 pages

Asthma - Pipeline Review, H1 2020

US$ 2,500.00

... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 758 pages

Overactive Bladder - Pipeline Review, H1 2020

US$ 2,000.00

... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 127 pages

Ulcerative Colitis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 671 pages

Allergic Conjunctivitis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Allergic Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 97 pages

Bronchiectasis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Bronchiectasis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 90 pages

Eosinophilic Esophagitis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Eosinophilic Esophagitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Eosinophilic Esophagitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 131 pages

Klebsiella pneumoniae Infections - Pipeline Review, H1 2020

US$ 2,000.00

... . The Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 128 pages

Polycystic Kidney Disease - Pipeline Review, H1 2020

US$ 2,000.00

... . The Polycystic Kidney Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Kidney Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 127 pages

Rosacea - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Rosacea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Rosacea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 90 pages

Yellow Fever - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Yellow Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Yellow Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 57 pages

Cystic Fibrosis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 502 pages

Sickle Cell Disease - Pipeline Review, H1 2020

US$ 2,000.00

... . The Sickle Cell Disease (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 271 pages

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 92 pages

Post Menopausal Osteoporosis - Pipeline Review, H1 2020

US$ 2,000.00

... . The Post Menopausal Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Post Menopausal Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 129 pages

Rabies - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Rabies (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rabies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 96 pages

Optic Neuritis - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Optic Neuritis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Optic Neuritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 48 pages

Oropharyngeal Cancer - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 550 pages

Vitiligo - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 144 pages

Acinetobacter Infections - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Acinetobacter Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 192 pages

Cataract - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Cataract (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Cataract and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 40 pages

Gastric Cancer - Pipeline Review, H1 2020

US$ 2,500.00

... releases. The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

April 2020 2197 pages

Haemophilus influenzae Type B Infections - Pipeline Review, H1 2020

US$ 2,000.00

... . The Haemophilus influenzae Type B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Haemophilus influenzae Type B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 69 pages

Inclusion Body Myositis (IBM) - Pipeline Review, H1 2020

US$ 2,000.00

... . The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 70 pages

Low Back Pain - Pipeline Review, H1 2020

US$ 2,000.00

... . The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development ...

April 2020 130 pages

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020

US$ 2,000.00

... releases. The Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Basal Cell Carcinoma (Basal Cell Epithelioma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2020 403 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers